If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
95.25    -1.25 (-1.30%)
Bid:
93.50
Ask:
97.00
Spread: 3.50 (3.743%)
Market Cap: £56.71m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Director/PDMR Shareholding

31 Dec 2020 07:00

RNS Number : 2011K
Crystal Amber Fund Limited
31 December 2020
 

31 December 2020

 

Crystal Amber Fund Limited

(the "Company")

 

Notification of Transactions of Person Discharging Managerial Responsibilities (PDMRs) and Person Closely Associated with Persons Discharging Managerial Responsibilities (PCAs)

The Company has been notified that the Investment Manager, Crystal Amber Asset Management (Guernsey) Limited, a PDMR of the Company has purchased 100,000 ordinary shares in the Company ("Ordinary Shares"). Following the transaction, Crystal Amber Asset Management (Guernsey) Limited holds 7,137,991 Ordinary Shares equivalent to 8.45 per cent. of the Company's voting rights.

Crystal Amber Fund also announces that it has been advised that Juan Morera, an employee of the Investment Adviser to the Company, has sold 50,000 Ordinary Shares.

Details of the transactions can be found in the Notification of Dealing Forms below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Juan Morera

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Employee of Investment Adviser

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Crystal Amber Fund Limited

b)

 

LEI

 

213800662E2XKP9JD811

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

CRYSTAL AMBER FUND LIMITED, ORDINARY SHARES

 

 

GG00B1Z2SL48

 

b)

 

Nature of the transaction

 

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

Price(s)£0.985

Volume(s)

50,000

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

50,000

£0.985

£49,250

e)

 

Date of the transaction

 

30 December 2020

f)

 

Place of the transaction

 

London Stock Exchange, AIM Market

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Crystal Amber Asset Management (Guernsey) Limited

2

 

Reason for the notification

 

a)

 

Position/status

 

Investment Manager

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Crystal Amber Fund Limited

b)

 

LEI

 

213800662E2XKP9JD811

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

CRYSTAL AMBER FUND LIMITED, ORDINARY SHARES

 

 

GG00B1Z2SL48

 

b)

 

Nature of the transaction

 

Purchase of Ordinary shares

c)

 

Price(s) and volume(s)

 

Price(s)£0.98

£0.985

Volume(s)

50,000

50,000

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

100,000

£0.9825

£98,250

e)

 

Date of the transactions

 

30 December 2020

f)

 

Place of the transactions

 

50,000 shares - London Stock Exchange, AIM Market

50,000 shares - Off-market

 

 

For further enquiries please contact: 

 

 

Crystal Amber Fund Limited

 

Christopher Waldron (Chairman)

Tel: 01481 742 742

 

 

Allenby Capital Limited - Nominated Adviser

 

David Worlidge/Liz Kirchner

Tel: 020 3328 5656

 

 

Winterflood Investment Trusts - Broker

 

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

 

Richard Bernstein

Tel: 020 7478 9080

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFEDFDLIVII
Date   Source Headline
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20244:01 pmRNSHolding(s) in Company
16th Aug 20249:45 amRNSDirector/PDMR Shareholding
16th Aug 20249:43 amRNSTransaction in Own Shares and Total Voting Rights
15th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Aug 20247:00 amRNSExtension to Share Buyback Programme
31st Jul 20245:00 pmRNSTotal Voting Rights
31st Jul 202411:50 amRNSInvestee company update: Morphic Medical Inc.
31st Jul 202411:07 amRNSMonthly Net Asset Value
26th Jul 20244:06 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jul 20246:04 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20245:42 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20245:15 pmRNSTotal Voting Rights
21st Jun 20245:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jun 202410:07 amRNSMonthly Net Asset Value
18th Jun 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 20244:49 pmRNSTransaction in Own Shares and Total Voting Rights
6th Jun 20245:15 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jun 20245:43 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNSMorphic Medical – FDA approval of study amendments
3rd Jun 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20245:39 pmRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
23rd May 20241:21 pmRNSMonthly Net Asset Value
23rd May 20247:00 amRNSExtension to Share Buyback Programme
22nd May 20247:00 amRNSTransaction in Own Shares
17th May 20245:49 pmRNSTransaction in Own Shares
3rd May 20246:22 pmRNSHolding(s) in Company
2nd May 202412:37 pmRNSHolding(s) in Company
1st May 20245:22 pmRNSTransaction in Own Shares
30th Apr 20245:37 pmRNSTotal Voting Rights
29th Apr 20243:26 pmRNSHolding(s) in Company
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20247:00 amRNSHolding(s) in Company
24th Apr 20244:00 pmRNSMonthly Net Asset Value
24th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20246:22 pmRNSTransaction in Own Shares
10th Apr 20249:34 amRNSTransaction in Own Shares
3rd Apr 20244:44 pmRNSMonthly Net Asset Value
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:30 pmRNSExtension to Share Buyback Programme
28th Mar 20246:01 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20246:27 pmRNSTransaction in Own Shares
22nd Mar 20245:09 pmRNSTransaction in Own Shares
18th Mar 20245:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.